You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Beyond Blame: Development of an online media literacy curriculum for violence prevention
SBC: KLEIN BUENDEL, INC. Topic: CDCThe Centers for Disease Control has determined that “youth violence is a serious public health problem that can have a long-term impact on health and well-being,” disproportionately impacting communities of color.” Violence prevention efforts, including education programs, are recommended to combat the negative impacts of violence. A number of factors exist that may increase or decrease the ...
SBIR Phase I 2023 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Innovative Continuous Sanitization of Fresh Produce Harvesting Equipment
SBC: En Solucion Inc Topic: FDARecent foodborne illness outbreaks traced to contaminated field harvesting equipment have highlighted the need for incorporating improved sanitization practices at the time of harvest. Field- harvested specialty crops represent 50% of the top ten foods linked to major recalls and outbreaks over the past five years. Proper sanitization of outdoor harvest equipment is made complicated by operational ...
SBIR Phase I 2023 Department of Health and Human ServicesFood and Drug Administration -
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
SBC: VITAN-BIOTECH LLC Topic: 300Project SummaryA broad range of neurological indications, including schizophrenia, pain, Parkinson's and Alzheimer's diseases, and autism have been linked to G-protein coupled receptor proteins (GPCRs), making them attractive targets for therapy. Understanding GPCR dysfunction is essential for effective therapeutic development. However, deciphering the functions of GPCRs remains a daunting task in ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients
SBC: Allander Biotechnologies Topic: NIDCRSummary Oral mucositis, a severe oral ulceration, is a common toxic effect of radio- or chemoradio-therapy (RT or CRT) and a limiting factor to using the optimal dose of radiation for effective cancer treatment. Intensity modulated RT (IMRT) and stereotactic Body RT (SBRT) spare more normal tissues and lessen chronic side effects, but not oral mucosa in head and neck cancer patients. To date, Pali ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Advanced Pediatric Airway Trainer for Enhanced Clinical Education in Pediatric Critical Care
SBC: TDA RESEARCH, INC. Topic: NICHDProject Summary/Abstract Clinical training aids such as surgical mannequins and procedural trainers are important tools for teaching proper technique to physicians and first responders. However, the majority of these training tools were developed for adult anatomies. Pediatric patients are often more challenging to treat, but few resources exist for advanced simulation in pediatric critical care e ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Amino Acids and Pediatric Hepatic Steatosis
SBC: THE AMINO COMPANY LLC Topic: 3007. Project Summary/Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in North America (1). Hepatic steatosis (HS) is the hallmark of NAFLD (2). NAFLD may transition in sub-groups to chronic inflammation (non- alcoholic steatohepatitis, NASH), and ultimately to cirrhosis. HS is prevalent in all stages of NAFLD. 3-10% of all children in the US and 40-70% of obese ch ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
The Point Powered: A Robust Actuated Prosthetic Finger for Partial Hand Amputation
SBC: POINT DESIGNS, LLC Topic: NIBIBABSTRACT Approximately 600,000 people live with partial hand limb loss (PHLL) in the United States, with an estimated 14,500 new cases occurring each year. Despite the advances in miniaturized electronics and motors, there has been very little advancement in mechatronic prosthetic digits for this underserved patient population. In fact, to date, there is only one myoelectric prosthetic option for ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a
SBC: CERIA THERAPEUTICS INC Topic: NHLBISUMMARYAcute respiratory distress syndrome (ARDS) accounts for 10% of ICU admissions worldwide, with a mortality as high as 46%. ARDS incidence has risen dramatically during the COVID-19 pandemic. Despite improvements in critical care and early detection of lung injury, the management of ARDS remains largely supportive. Although mechanical ventilation may provide the necessary life support, impair ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
A ratcheting pediatric prosthetic finger using advanced rapid manufacturing technology
SBC: POINT DESIGNS, LLC Topic: NICHDA ratcheting pediatric prosthetic finger using advancedrapid manufacturing technology ABSTRACT The goal of the proposed project is to develop and commercialize a purely mechanical, ratcheting pediatric prosthetic finger – the Point Mini – which 1) has an industry leading strength to weight ratio, 2) can be operated unilaterally (one-handed), 3) offers anatomical rotation and flexion around the ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of an AI-empowered device that utilizes multimodal data-visualization to aid in the diagnosis, and treatment, of OUD
SBC: WAVi Co. Topic: NIDAAbstract Assessing the effectiveness of opioid use disorder (OUD), where high relapse rates create financial and social tolls, is a pressing clinical problem in need of better measurement tools. The ability to identify cognitive changes should improve outcomes but current intake into rehabilitation programs doesn’t typically include cognitive tests. Simple, quick, cost-effective, and objective m ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health